NVAX

RSV Vaccine

RSV - Pediatrics

Stage (next event)

Expected Date

Phase 1

Catalyst Info & Data Links

Catalyst Event

  • TBA


Clinical Trial

  • NCT02296463: A Phase I Randomized, Observer-Blinded, Dose-Ranging Study in Healthy Subjects 24 to <72 Months of Age


Related Links


Prior Work

September 29, 2015: Phase 1 Topline Data

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See what the community is saying - click to see full post

3Q2016 Hedge Fund Activity Related to AMP Portfolio companies

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon